Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms

Brain Research

Volumn 1655, Issue , 2017, Pages 283-293

  Flaherty, Erin K ^a   Brennand, Kristen J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CNV; Hipsc models; Mouse models; Schizophrenia

Indexed keywords

COPY NUMBER VARIATION; DRUG DEVELOPMENT; GENETIC ENGINEERING; GENOME ANALYSIS; GENOME EDITING; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MOUSE MODEL; NEUROPSYCHIATRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; ANIMAL; GENETICS; MENTAL DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DNA COPY NUMBER VARIATIONS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MENTAL DISORDERS;

EID: 84947547489     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.11.009     Document Type: Review

References (114)

1. Adamo, A., Atashpaz, S., Germain, P.-L., Zanella, M., D'Agostino, G., Albertin, V., Chenoweth, J., Micale, L., Fusco, C., Unger, C., Augello, B., Palumbo, O., Hamilton, B., Carella, M., Donti, E., Pruneri, G., Selicorni, A., Biamino, E., Prontera, P., McKay, R., Merla, G., Testa, G., 7Q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages. Nat. Genet. 47 (2014), 132–141, 10.1038/ng.3169.
2. Ahn, K., An, S.S., Shugart, Y.Y., Rapoport, J.L., Common polygenic variation and risk for childhood-onset schizophrenia. Mol. Psychiatry, 2014, 1–3, 10.1038/mp.2014.158.
3. Ahn, K., Gotay, N., Andersen, T.M., Anvari, a a, Gochman, P., Lee, Y., Sanders, S., Guha, S., Darvasi, A., Glessner, J.T., Hakonarson, H., Lencz, T., State, M.W., Shugart, Y.Y., Rapoport, J.L., High rate of disease-related copy number variations in childhood onset schizophrenia. Mol. Psychiatry 19 (2014), 568–572, 10.1038/mp.2013.59.
4. Allen, A.J., Griss, M.E., Folley, B.S., Hawkins, K. a, Pearlson, G.D., Endophenotypes in schizophrenia: a selective review. Schizophr. Res. 109 (2009), 24–37, 10.1016/j.schres.2009.01.016.
5. Ananiev, G., Williams, E.C., Li, H., Chang, Q., Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One, 6, 2011, e25255, 10.1371/journal.pone.0025255.
6. Batzoglou, S., Human and mouse gene structure: comparative analysis and application to exon prediction. Genome Res. 10 (2000), 950–958, 10.1101/gr.10.7.950.
7. Braff, D.L., Freedman, R., Schork, N.J., Gottesman, I.I., Deconstructing Schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 33 (2006), 21–32, 10.1093/schbul/sbl049.
8. Brennand, K., Savas, J.N., Kim, Y., Tran, N., Simone, a, Hashimoto-Torii, K., Beaumont, K.G., Kim, H.J., Topol, a, Ladran, I., Abdelrahim, M., Matikainen-Ankney, B., Chao, S.-H., Mrksich, M., Rakic, P., Fang, G., Zhang, B., Yates, J.R., Gage, F.H., Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psychiatry 20 (2014), 1–8, 10.1038/mp.2014.22.
9. Brennand, K.J., Landek-Salgado, M.A., Sawa, A., Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. Biol. Psychiatry 75 (2014), 936–944, 10.1016/j.biopsych.2013.10.025.
10. Brennand, K.J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., McCarthy, S., Sebat, J., Gage, F.H., Modelling schizophrenia using human induced pluripotent stem cells. Nature 473 (2011), 221–225, 10.1038/nature09915.
11. Chen, J., Cao, F., Liu, L., Wang, L., Chen, X., Genetic studies of schizophrenia: an update. Neurosci. Bull. 31 (2015), 87–98, 10.1007/s12264-014-1494-4.
12. Chen, X., Shen, Y., Zhang, F., Chiang, C., Pillalamarri, V., Blumenthal, I., Talkowski, M., Wu, B.L., Gusella, J.F., Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs. Am. J. Hum. Genet. 92 (2013), 375–386, 10.1016/j.ajhg.2013.02.006.
13. Chiang, C.-H., Su, Y., Wen, Z., Yoritomo, N., Ross, C.A., Margolis, R.L., Song, H., Ming, G., Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 16 (2011), 358–360, 10.1038/mp.2011.13.
14. Chun, S., Westmoreland, J.J., Bayazitov, I.T., Eddins, D., Pani, A.K., Smeyne, R.J., Yu, J., Blundon, J.A., Zakharenko, S.S., Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models. Science 344 (2014), 1178–1182, 10.1126/science.1253895 (80-.).
15. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., Zhang, F., Multiplex genome engineering using CRISPR/Cas systems. Science 80:339 (2013), 819–823, 10.1126/science.1231143.
16. Conrad, D.F., Keebler, J.E.M., DePristo, M.A., Lindsay, S.J., Zhang, Y., Casals, F., Idaghdour, Y., Hartl, C.L., Torroja, C., Garimella, K.V., Zilversmit, M., Cartwright, R., Rouleau, G.A., Daly, M., Stone, E.A., Hurles, M.E., Awadalla, P., Variation in genome-wide mutation rates within and between human families. Nat. Genet. 43 (2011), 712–714, 10.1038/ng.862.
17. Cunningham, M., Cho, J.-H., Leung, A., Savvidis, G., Ahn, S., Moon, M., Lee, P.K.J., Han, J.J., Azimi, N., Kim, K.-S., Bolshakov, V.Y., Chung, S., hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell 15 (2014), 559–573, 10.1016/j.stem.2014.10.006.
18. Demjaha, A., Egerton, A., Murray, R.M., Kapur, S., Howes, O.D., Stone, J.M., McGuire, P.K., Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function. Biol. Psychiatry 75 (2014), e11–e13, 10.1016/j.biopsych.2013.06.011.
19. Diener, H.C., Lees, K.R., Lyden, P., Grotta, J., Davalos, A., Davis, S.M., Shuaib, A., Ashwood, T., Wasiewski, W., Alderfer, V., Hårdemark, H.G., Rodichok, L., NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 39 (2008), 1751–1758, 10.1161/STROKEAHA.107.503334.
20. Drew, L.J., Crabtree, G.W., Markx, S., Stark, K.L., Chaverneff, F., Xu, B., Mukai, J., Fenelon, K., Hsu, P., Gogos, J.A., Karayiorgou, M., The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int. J. Dev. Neurosci. 29 (2011), 259–281, 10.1016/j.ijdevneu.2010.09.007.
21. Esclassan, F., Francois, J., Phillips, K.G., Loomis, S., Gilmour, G., Phenotypic characterization of nonsocial behavioral impairment in neurexin 1α knockout rats. Behav. Neurosci. 129 (2015), 74–85, 10.1037/bne0000024.
22. Espuny-Camacho, I., Michelsen, K. a, Gall, D., Linaro, D., Hasche, A., Bonnefont, J., Bali, C., Orduz, D., Bilheu, A., Herpoel, A., Lambert, N., Gaspard, N., Péron, S., Schiffmann, S.N., Giugliano, M., Gaillard, A., Vanderhaeghen, P., Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77 (2013), 440–456, 10.1016/j.neuron.2012.12.011.
23. Etherton, M.R., Blaiss, C. a, Powell, C.M., Südhof, T.C., Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 17998–18003, 10.1073/pnas.0910297106.
24. Fejgin, K., Nielsen, J., Birknow, M.R., Bastlund, J.F., Nielsen, V., Lauridsen, J.B., Stefansson, H., Steinberg, S., Sorensen, H.B.D., Mortensen, T.E., Larsen, P.H., Klewe, I.V., Rasmussen, S.V., Stefansson, K., Werge, T.M., Kallunki, P., Christensen, K.V., Didriksen, M., A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations. Biol. Psychiatry 76 (2014), 128–137, 10.1016/j.biopsych.2013.08.014.
25. Forstner, A.J., Degenhardt, F., Schratt, G., Nöthen, M.M., MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review. Front. Mol. Neurosci, 6, 2013, 47, 10.3389/fnmol.2013.00047.
26. Galili, N., Baldwin, H.S., Lund, J., Reeves, R., Gong, W., Wang, Z., Roe, B. a, Emanuel, B.S., Nayak, S., Mickanin, C., Budarf, M.L., Buck, C., A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region. Genome Res. 7 (1997), 17–26.
27. Geaghan, M., Cairns, M.J., MicroRNA and posttranscriptional dysregulation in psychiatry. Biol. Psychiatry, 2014, 1–9, 10.1016/j.biopsych.2014.12.009.
28. Germain, N.D., Chen, P.-F., Plocik, A.M., Glatt-Deeley, H., Brown, J., Fink, J.J., Bolduc, K.a, Robinson, T.M., Levine, E.S., Reiter, L.T., Graveley, B.R., Lalande, M., Chamberlain, S.J., Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1. Mol. Autism, 5, 2014, 44, 10.1186/2040-2392-5-44.
29. Grayton, H.M., Missler, M., Collier, D.A., Fernandes, C., Altered social behaviours in neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders. PLoS One, 8, 2013, e67114, 10.1371/journal.pone.0067114.
30. Grskovic, M., Javaherian, A., Strulovici, B., Daley, G.Q., Induced pluripotent stem cells — opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov., 2011, 10, 10.1038/nrd3577.
31. Han, J., The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 18 (2004), 3016–3027, 10.1101/gad.1262504.
32. Health, N.I. of M., 2013. The Numbers Count : Mental Disorders in America [WWW Document]. nimh.nih.gov. URL www.nimh.nih.gov/health/publications/the-numbers-count-mental-disorders-in-america/index.shtml.
33. Hiroi, N., Takahashi, T., Hishimoto, A., Izumi, T., Boku, S., Hiramoto, T., Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol. Psychiatry 18 (2013), 1153–1165, 10.1038/mp.2013.92.
34. Ho, S., Topol, A., Brennand, K.J., From “directed differentiatio” to “neuronal induction”: modeling neuropsychiatric disease. Biomark. Insights, 10, 2015, 31, 10.4137/BMI.S20066.
35. Hook, V., Brennand, K.J., Kim, Y., Toneff, T., Funkelstein, L., Lee, K.C., Ziegler, M., Gage, F.H., Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons. Stem Cell Reports 3 (2014), 531–538, 10.1016/j.stemcr.2014.08.001.
36. Horev, G., Ellegood, J., Lerch, J.P., Son, Y.-E.E., Muthuswamy, L., Vogel, H., Krieger, A.M., Buja, A., Henkelman, R.M., Wigler, M., Mills, A.A., Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc. Natl. Acad. Sci. 108 (2011), 17076–17081, 10.1073/pnas.1114042108.
37. Hsu, P.D., Lander, E.S., Zhang, F., Development and applications of CRISPR-Cas9 for genome engineering. Cell 157 (2014), 1262–1278, 10.1016/j.cell.2014.05.010.
38. International, T., Consortium, S., Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (2008), 237–241, 10.1038/nature07239.
39. Jiang, W., Bikard, D., Cox, D., Zhang, F., Marraffini, L., RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31 (2013), 233–239, 10.1038/nbt.2508.
40. Johnson, M.B., Kawasawa, Y.I., Mason, C.E., Krsnik, Ž., Coppola, G., Bogdanović, D., Geschwind, D.H., Mane, S.M., State, M.W., Šestan, N., Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 62 (2009), 494–509, 10.1016/j.neuron.2009.03.027.
41. Kalsner, L., Chamberlain, S.J., Prader–Willi, Angelman, and 15q11–q13 duplication syndromes. Pediatr. Clin. North Am. 62 (2015), 587–606.
42. Karayiorgou, M., Simon, T.J., Gogos, J. a, 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 11 (2010), 402–416, 10.1038/nrn2841.
43. Kellendonk, C., Simpson, E.H., Kandel, E.R., Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci. 32 (2009), 347–358, 10.1016/j.tins.2009.02.003.
44. Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K.K., Holmans, P., Craddock, N., Owen, M.J., O'Donovan, M.C., Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 18 (2009), 1497–1503, 10.1093/hmg/ddp043.
45. Kirov, G., Pocklington, A., Holmans, P.A., Ivanov, D.K., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., Grozeva, D.V., Fjodorova, M., Wollerton, R.L., Rees, E., Nikolova, I., van de Lagemaat, L.N., Bayés, À., Fernandez, E., Olason, P.I., Böttcher, Y., Komiyama, N.H., Collins, M.O., Choudhary, J., Stefansson, K., Stefansson, H., Grant, S.G.N., Purcell, S., Sklar, P., O'Donovan, M.C., Owen, M.J., De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry, 2011, 142–153, 10.1038/mp.2011.154.
46. Kirov, G., Rees, E., Walters, J.T.R., Escott-Price, V., Georgieva, L., Richards, A.L., Chambert, K.D., Davies, G., Legge, S.E., Moran, J.L., McCarroll, S.A., O'Donovan, M.C., Owen, M.J., The Penetrance of copy number variations for schizophrenia and developmental delay. Biol. Psychiatry 75 (2014), 378–385, 10.1016/j.biopsych.2013.07.022.
47. Ko, H.C., Gelb, B.D., Concise review: drug discovery in the age of the induced pluripotent stem cell. Stem Cells Trans. Med. 3 (2014), 500–509, 10.5966/sctm.2013-0162.
48. Konermann, S., Brigham, M.D., Trevino, A.E., Joung, J., Abudayyeh, O.O., Barcena, C., Hsu, P.D., Habib, N., Gootenberg, J.S., Nishimasu, H., Nureki, O., Zhang, F., Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517 (2014), 583–588, 10.1038/nature14136.
49. Kriks, S., Shim, J.-W., Piao, J., Ganat, Y.M., Wakeman, D.R., Xie, Z., Carrillo-Reid, L., Auyeung, G., Antonacci, C., Buch, A., Yang, L., Beal, M.F., Surmeier, D.J., Kordower, J.H., Tabar, V., Studer, L., Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480 (2011), 547–551, 10.1038/nature10648.
50. Laarakker, M.C., Reinders, N.R., Bruining, H., Ophoff, R. a, Kas, M.J.H., Sex-dependent novelty response in neurexin-1?? mutant mice. PLoS One 7 (2012), 3–8, 10.1371/journal.pone.0031503.
51. Larimore, J., Ryder, P.V, Kim, K.-Y., Ambrose, L.A., Chapleau, C., Calfa, G., Gross, C., Bassell, G.J., Pozzo-Miller, L., Smith, Y., Talbot, K., Park, I.-H., Faundez, V., MeCP2 Regulates the Synaptic Expression of a Dysbindin-BLOC-1 Network Component in Mouse Brain and Human Induced Pluripotent Stem Cell-Derived Neurons. PLoS One, 8, 2013, e65069, 10.1371/journal.pone.0065069.
52. Larson, M.H., Gilbert, L. a, Wang, X., Lim, W. a, Weissman, J.S., Qi, L.S., CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8 (2013), 2180–2196, 10.1038/nprot.2013.132.
53. Li, H.H., Roy, M., Kuscuoglu, U., Spencer, C.M., Halm, B., Harrison, K.C., Bayle, J.H., Splendore, A., Ding, F., Meltzer, L. a, Wright, E., Paylor, R., Deisseroth, K., Francke, U., Induced chromosome deletions cause hypersociability and other features of Williams–Beuren syndrome in mice. EMBO Mol. Med. 1 (2009), 50–65, 10.1002/emmm.200900003.
54. Liu, J., Koscielska, K.a., Cao, Z., Hulsizer, S., Grace, N., Mitchell, G., Nacey, C., Githinji, J., McGee, J., Garcia-Arocena, D., Hagerman, R.J., Nolta, J., Pessah, I.N., Hagerman, P.J., Signaling defects in iPSC-derived fragile X premutation neurons. Hum. Mol. Genet. 21 (2012), 3795–3805, 10.1093/hmg/dds207.
55. Long, J.M., LaPorte, P., Merscher, S., Funke, B., Saint-Jore, B., Puech, A., Kucherlapati, R., Morrow, B.E., Skoultchi, A.I., Wynshaw-Boris, A., Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 7 (2006), 247–257, 10.1007/s10048-006-0054-0.
56. Maeder, M.L., Linder, S.J., Cascio, V.M., Fu, Y., Ho, Q.H., Joung, J.K., CRISPR RNA–guided activation of endogenous human genes. Nat. Methods 10 (2013), 977–979, 10.1038/nmeth.2598.
57. Malhotra, D., Sebat, J., CNVs: Harbingers of a rare variant revolution in psychiatric genetics. Cell 148 (2012), 1223–1241, 10.1016/j.cell.2012.02.039.
58. Mariani, J., Simonini, M.V., Palejev, D., Tomasini, L., Coppola, G., Szekely, A.M., Horvath, T.L., Vaccarino, F.M., Modeling human cortical development in vitro using induced pluripotent stem cells. Proc. Natl. Acad. Sci. 109 (2012), 12770–12775, 10.1073/pnas.1202944109.
59. Maroof, A.M., Keros, S., Tyson, J.A., Ying, S.-W., Ganat, Y.M., Merkle, F.T., Liu, B., Goulburn, A., Stanley, E.G., Elefanty, A.G., Widmer, H.R., Eggan, K., Goldstein, P.A., Anderson, S.A., Studer, L., Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 12 (2013), 559–572, 10.1016/j.stem.2013.04.008.
60. McCarthy, S.E., Makarov, V., Kirov, G., Addington, A.M., McClellan, J., Yoon, S., Perkins, D.O., Dickel, D.E., Kusenda, M., Krastoshevsky, O., Krause, V., Kumar, R. a, Grozeva, D., Malhotra, D., Walsh, T., Zackai, E.H., Kaplan, P., Ganesh, J., Krantz, I.D., Spinner, N.B., Roccanova, P., Bhandari, A., Pavon, K., Lakshmi, B., Leotta, A., Kendall, J., Lee, Y.-H., Vacic, V., Gary, S., Iakoucheva, L.M., Crow, T.J., Christian, S.L., Lieberman, J. a, Stroup, T.S., Lehtimäki, T., Puura, K., Haldeman-Englert, C., Pearl, J., Goodell, M., Willour, V.L., Derosse, P., Steele, J., Kassem, L., Wolff, J., Chitkara, N., McMahon, F.J., Malhotra, A.K., Potash, J.B., Schulze, T.G., Nöthen, M.M., Cichon, S., Rietschel, M., Leibenluft, E., Kustanovich, V., Lajonchere, C.M., Sutcliffe, J.S., Skuse, D., Gill, M., Gallagher, L., Mendell, N.R., Craddock, N., Owen, M.J., O'Donovan, M.C., Shaikh, T.H., Susser, E., Delisi, L.E., Sullivan, P.F., Deutsch, C.K., Rapoport, J., Levy, D.L., King, M.-C., Sebat, J., Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 41 (2009), 1223–1227, 10.1038/ng.474.
61. Meechan, D.W., Tucker, E.S., Maynard, T.M., LaMantia, A.-S., Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. Proc. Natl. Acad. Sci. 109 (2012), 18601–18606, 10.1073/pnas.1211507109.
62. Meechan, D.W., Tucker, E.S., Maynard, T.M., LaMantia, A.-S., Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 16434–16445, 10.1073/pnas.0905696106.
63. Merscher, S., Funke, B., Epstein, J. a, Heyer, J., Puech, A., Lu, M.M., Xavier, R.J., Demay, M.B., Russell, R.G., Factor, S., Tokooya, K., Jore, B.S., Lopez, M., Pandita, R.K., Lia, M., Carrion, D., Xu, H., Schorle, H., Kobler, J.B., Scambler, P., Wynshaw-Boris, A., Skoultchi, A.I., Morrow, B.E., Kucherlapati, R., TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104 (2001), 619–629, 10.1016/S0092-8674(01)00247-1.
64. Miller, J.C., Holmes, M.C., Wang, J., Guschin, D.Y., Lee, Y.-L., Rupniewski, I., Beausejour, C.M., Waite, A.J., Wang, N.S., Kim, K.A., Gregory, P.D., Pabo, C.O., Rebar, E.J., An improved zinc-finger nuclease architecture for highly specific genome editing. Nat. Biotechnol. 25 (2007), 778–785, 10.1038/nbt1319.
65. Mills, R.E., Walter, K., Stewart, C., Handsaker, R.E., Chen, K., Alkan, C., Abyzov, A., Yoon, S.C., Ye, K., Cheetham, R.K., et al. Mapping copy number variation by population-scale genome sequencing. Nature 470 (2011), 59–65, 10.1038/nature09708.Mapping.
66. Missler, M., Südhof, T.C., Neurexins: Three genes and 1001 products. Trends Genet. 14 (1998), 20–26, 10.1016/S0168-9525(97)01324-3.
67. Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R.E., Gottmann, K., Südhof, T.C., Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423 (2003), 939–948, 10.1038/nature01755.
68. Mukai, J., Dhilla, A., Drew, L.J., Stark, K.L., Cao, L., MacDermott, A.B., Karayiorgou, M., Gogos, Ja, Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11 (2008), 1302–1310, 10.1038/nn.2204.
69. Mukai, J., Tamura, M., Fénelon, K., Rosen, A.M., Spellman, T.J., Kang, R., MacDermott, A.B., Karayiorgou, M., Gordon, J.A., Gogos, J.A., Molecular Substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia. Neuron, 2015, 680–695, 10.1016/j.neuron.2015.04.003.
70. Neale, B.M., Sklar, P., Genetic analysis of schizophrenia and bipolar disorder reveals polygenicity but also suggests new directions for molecular interrogation. Curr. Opin. Neurobiol. 30 (2015), 131–138, 10.1016/j.conb.2014.12.001.
71. Nestor, M.W., Phillips, A.W., Artimovich, E., Nestor, J.E., Hussman, J.P., Blatt, G.J., 2015. Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies. Autism Res. n/a–n/a. doi:10.1002/aur.1570.
72. Nicholas, C.R., Chen, J., Tang, Y., Southwell, D.G., Chalmers, N., Vogt, D., Arnold, C.M., Chen, Y.-J.J., Stanley, E.G., Elefanty, A.G., Sasai, Y., Alvarez-Buylla, A., Rubenstein, J.L.R., Kriegstein, A.R., Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12 (2013), 573–586, 10.1016/j.stem.2013.04.005.
73. Park, C., Halevy, T., Lee, D.R., Sung, J.J., Lee, J.S., Yanuka, O., Benvenisty, N., Kim, D., Reversion of FMR1 methylation and silencing by editing the triplet repeats in fragile X iPSC-derived neurons. Cell Rep, 2015, 1–8, 10.1016/j.celrep.2015.08.084.
74. Paşca, A.M., Sloan, S. a, Clarke, L.E., Tian, Y., Makinson, C.D., Huber, N., Kim, C.H., Park, J.-Y., O'Rourke, N. a, Nguyen, K.D., Smith, S.J., Huguenard, J.R., Geschwind, D.H., Barres, B. a, Paşca, S.P., Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods, 2015, 12, 10.1038/nmeth.3415.
75. Paulsen, B., da, S., Maciel, R., de, M., Galina, A., da Silveira, M.S., Souza, C., dos, S., Drummond, H., Pozzatto, E.N., Junior, H.S., Chicaybam, L., Massuda, R., Setti-Perdigão, P., Bonamino, M., Belmonte-de-Abreu, P.S., Castro, N.G., Brentani, H., Rehen, S.K., Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant. 21 (2012), 1547–1559, 10.3727/096368911X600957.
76. Paylor, R., Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum. Mol. Genet. 10 (2001), 2645–2650, 10.1093/hmg/10.23.2645.
77. Paylor, R., Lindsay, E., Mouse models of 22q11 deletion syndrome. Biol. Psychiatry 59 (2006), 1172–1179, 10.1016/j.biopsych.2006.01.018.
78. Pocklington, A.J., Rees, E., Walters, J.T.R., Han, J., Kavanagh, D.H., Chambert, K.D., Holmans, P., Moran, J.L., McCarroll, S.A., Kirov, G., O'Donovan, M.C., Owen, M.J., Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron 86 (2015), 1203–1214, 10.1016/j.neuron.2015.04.022.
79. Purcell, S.M., Moran, J.L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O'Dushlaine, C., Chambert, K., Bergen, S.E., Kähler, A., Duncan, L., Stahl, E., Genovese, G., Fernández, E., Collins, M.O., Komiyama, N.H., Choudhary, J.S., Magnusson, P.K.E., Banks, E., Shakir, K., Garimella, K., Fennell, T., DePristo, M., Grant, S.G.N., Haggarty, S.J., Gabriel, S., Scolnick, E.M., Lander, E.S., Hultman, C.M., Sullivan, P.F., McCarroll, S. a, Sklar, P., A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506 (2014), 185–190, 10.1038/nature12975.
80. Rabaneda, L.G., Robles-Lanuza, E., Nieto-González, J., Scholl, F.G., Neurexin dysfunction in adult neurons results in autistic-like behavior in mice. Cell Rep 8 (2014), 338–346, 10.1016/j.celrep.2014.06.022.
81. Ran, F.A., Hsu, P.P.D., Wright, J., Agarwala, V., Scott, D. a, Zhang, F., Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8 (2013), 2281–2308, 10.1038/nprot.2013.143.
82. Rees, E., Kirov, G., Sanders, a, Walters, J.T.R., Chambert, K.D., Shi, J., Szatkiewicz, J., O'Dushlaine, C., Richards, a L., Green, E.K., Jones, I., Davies, G., Legge, S.E., Moran, J.L., Pato, C., Pato, M., Genovese, G., Levinson, D., Duan, J., Moy, W., Göring, H.H.H., Morris, D., Cormican, P., Kendler, K.S., O'Neill, F. a, Riley, B., Gill, M., Corvin, a, Craddock, N., Sklar, P., Hultman, C., Sullivan, P.F., Gejman, P.V., McCarroll, S. a, O'Donovan, M.C., Owen, M.J., Evidence that duplications of 22q11.2 protect against schizophrenia. Mol. Psychiatry 19 (2014), 37–40, 10.1038/mp.2013.156.
83. Rees, E., Walters, J.T.R., Georgieva, L., Isles, A.R., Chambert, K.D., Richards, A.L., Mahoney-Davies, G., Legge, S.E., Moran, J.L., McCarroll, S. a, O'Donovan, M.C., Owen, M.J., Kirov, G., Analysis of copy number variations at 15 schizophrenia-associated loci. Br. J. Psychiatry 204 (2014), 108–114, 10.1192/bjp.bp.113.131052.
84. Ripke, S., Neale, B.M., Corvin, A., Walters, J.T.R., Farh, K.-H., Holmans, P. a, Lee, P., Bulik-Sullivan, B., Collier, D. a, Huang, H., Pers, T.H., Agartz, I., Agerbo, E., Albus, M., Alexander, M., Amin, F., Bacanu, S. a, Begemann, M., Belliveau Jr, R. a, Bene, J., Bergen, S.E., Bevilacqua, E., Bigdeli, T.B., Black, D.W., Bruggeman, R., Buccola, N.G., Buckner, R.L., Byerley, W., Cahn, W., Cai, G., Campion, D., Cantor, R.M., Carr, V.J., Carrera, N., Catts, S.V., Chambert, K.D., Chan, R.C.K., Chen, R.Y.L., Chen, E.Y.H., Cheng, W., Cheung, E.F.C., Ann Chong, S., Robert Cloninger, C., Cohen, D., Cohen, N., Cormican, P., Craddock, N., Crowley, J.J., Curtis, D., Davidson, M., Davis, K.L., Degenhardt, F., Del Favero, J., Demontis, D., Dikeos, D., Dinan, T., Djurovic, S., Donohoe, G., Drapeau, E., Duan, J., Dudbridge, F., Durmishi, N., Eichhammer, P., Eriksson, J., Escott-Price, V., Essioux, L., Fanous, A.H., Farrell, M.S., Frank, J., Franke, L., Freedman, R., Freimer, N.B., Friedl, M., Friedman, J.I., Fromer, M., Genovese, G., Georgieva, L., Giegling, I., Giusti-Rodríguez, P., Godard, S., Goldstein, J.I., Golimbet, V., Gopal, S., Gratten, J., de Haan, L., Hammer, C., Hamshere, M.L., Hansen, M., Hansen, T., Haroutunian, V., Hartmann, A.M., Henskens, F. a, Herms, S., Hirschhorn, J.N., Hoffmann, P., Hofman, A., Hollegaard, M.V., Hougaard, D.M., Ikeda, M., Joa, I., Julià, A., Kahn, R.S., Kalaydjieva, L., Karachanak-Yankova, S., Karjalainen, J., Kavanagh, D., Keller, M.C., Kennedy, J.L., Khrunin, A., Kim, Y., Klovins, J., Knowles, J. a, Konte, B., Kucinskas, V., Ausrele Kucinskiene, Z., Kuzelova-Ptackova, H., Kähler, A.K., Laurent, C., Keong, Lee Chee, Hong Lee, J., Legge, S., Lerer, S.E., Li, B., Li, M., Liang, T., Lieberman, K.-Y., Limborska, J., Loughland, S., Lubinski, C.M., Lönnqvist, J., Macek Jr, J., Magnusson, M., Maher, P.K.E., Maier, B.S., Mallet, W., Marsal, J., Mattheisen, S., Mattingsdal, M., McCarley, M., McDonald, R.W., McIntosh, C., Meier, A.M., Meijer, S., Melegh, C.J., Melle, B., Mesholam-Gately, I., Metspalu, R.I., Michie, A., Milani, P.T., Milanova, L., Mokrab, V., Morris, Y., Mors, D.W., Murphy, O., Murray, K.C., Myin-Germeys, R.M., Müller-Myhsok, I., Nelis, B., Nenadic, M., Nertney, I., Nestadt, D. a, Nicodemus, G., Nikitina-Zake, K.K., Nisenbaum, L., Nordin, L., O'Callaghan, A., O'Dushlaine, C., E., O'Neill, F.A., Oh, S.-Y., Olincy, A., Olsen, L., Van Os, J., Endophenotypes International Consortium, P., Pantelis, C., Papadimitriou, G.N., Papiol, S., Parkhomenko, E., Pato, M.T., Paunio, T., Pejovic-Milovancevic, M., Perkins, D.O., Pietiläinen, O., Pimm, J., Pocklington, A.J., Powell, J., Price, A., Pulver, A.E., Purcell, S.M., Quested, D., Rasmussen, H.B., Reichenberg, A., Reimers, M. a, Richards, A.L., Roffman, J.L., Roussos, P., Ruderfer, D.M., Salomaa, V., Sanders, A.R., Schall, U., Schubert, C.R., Schulze, T.G., Schwab, S.G., Scolnick, E.M., Scott, R.J., Seidman, L.J., Shi, J., Sigurdsson, E., Silagadze, T., Silverman, J.M., Sim, K., Slominsky, P., Smoller, J.W., So, H.-C., Spencer, C. a, Stahl, E. a, Stefansson, H., Steinberg, S., Stogmann, E., Straub, R.E., Strengman, E., Strohmaier, J., Scott Stroup, T., Subramaniam, M., Suvisaari, J., Svrakic, D.M., Szatkiewicz, J.P., Söderman, E., Thirumalai, S., Toncheva, D., Tosato, S., Veijola, J., Waddington, J., Walsh, D., Wang, D., Wang, Q., Webb, B.T., Weiser, M., Wildenauer, D.B., Williams, N.M., Williams, S., Witt, S.H., Wolen, A.R., Wong, E.H.M., Wormley, B.K., Simon Xi, H., Zai, C.C., Zheng, X., Zimprich, F., Wray, N.R., Stefansson, K., Visscher, P.M., Trust Case-Control Consortium, W., Adolfsson, R., Andreassen, O. a, Blackwood, D.H.R., Bramon, E., Buxbaum, J.D., Børglum, A.D., Cichon, S., Darvasi, A., Domenici, E., Ehrenreich, H., Esko, T., Gejman, P.V., Gill, M., Gurling, H., Hultman, C.M., Iwata, N., Jablensky, A.V., Jönsson, E.G., Kendler, K.S., Kirov, G., Knight, J., Lencz, T., Levinson, D.F., Li, Q.S., Liu, J., Malhotra, A.K., McCarroll, S. a, McQuillin, A., Moran, J.L., Mortensen, P.B., Mowry, B.J., Nöthen, M.M., Ophoff, R. a, Owen, M.J., Palotie, A., Pato, C.N., Petryshen, T.L., Posthuma, D., Rietschel, M., Riley, B.P., Rujescu, D., Sham, P.C., Sklar, P., St Clair, D., Weinberger, D.R., Wendland, J.R., Werge, T., Daly, M.J., Sullivan, P.F., O'Donovan, M.C., Biological insights from 108 schizophrenia-associated genetic loci. Nature 511 (2014), 421–427, 10.1038/nature13595.
85. Robicsek, O., Karry, R., Petit, I., Salman-Kesner, N., Müller, F.-J., Klein, E., Aberdam, D., Ben-Shachar, D., Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol. Psychiatry 18 (2013), 1067–1076, 10.1038/mp.2013.67.
86. Robinson, D.G., Woerner, M.G., McMeniman, M., Mendelowitz, A., Bilder, R.M., Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry 161 (2004), 473–479, 10.1176/appi.ajp.161.3.473.
87. Rodriguez-Revenga, L., Mila, M., Rosenberg, C., Lamb, A., Lee, C., Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. Genet. Med. 9 (2007), 600–606, 10.1097/GIM.0b013e318149e1e3.
88. Ronen, D., Benvenisty, N., Genomic stability in reprogramming. Curr. Opin. Genet. Dev. 22 (2012), 444–449, 10.1016/j.gde.2012.09.003.
89. Schadt, E.E., Buchanan, S., Brennand, K.J., Merchant, K.M., Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders. Front. Pharmacol. 5 (2014), 1–15, 10.3389/fphar.2014.00252.
90. Schlaeger, T.M., Daheron, L., Brickler, T.R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., Gupta, D., McPherson, J., Malwadkar, P., Gupta, M., Bell, B., Doi, A., Jung, N., Li, X., Lynes, M.S., Brookes, E., Cherry, A.B.C., Demirbas, D., Tsankov, A.M., Zon, L.I., Rubin, L.L., Feinberg, A.P., Meissner, A., Cowan, C. a, Daley, G.Q., A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33 (2014), 55–60, 10.1038/nbt.3070.
91. Schneider, M., Debbané, M., Bassett, A.S., Chow, E.W.C., Fung, W.L.A., van den Bree, M.B.M., Owen, M., Murphy, K.C., Niarchou, M., Kates, W.R., Antshel, K.M., Fremont, W., McDonald-McGinn, D.M., Gur, R.E., Zackai, E.H., Vorstman, J., Duijff, S.N., Klaassen, P.W.J., Swillen, A., Gothelf, D., Green, T., Weizman, A., Van Amelsvoort, T., Evers, L., Boot, E., Shashi, V., Hooper, S.R., Bearden, C.E., Jalbrzikowski, M., Armando, M., Vicari, S., Murphy, D.G., Ousley, O., Campbell, L.E., Simon, T.J., Eliez, S., Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. Am. J. Psychiatry 171 (2014), 627–639, 10.1176/appi.ajp.2013.13070864.
92. Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J.a., Hallmayer, J.F., Dolmetsch, R.E., SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503 (2013), 267–271, 10.1038/nature12618.
93. Shi, Y., Kirwan, P., Smith, J., Robinson, H.P.C., Livesey, F.J., Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 15 (2012), 477–486, 10.1038/nn.3041.
94. Sigurdsson, T., Stark, K.L., Karayiorgou, M., Gogos, J. a, Gordon, J. a, Impaired hippocampal–prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 464 (2010), 763–767, 10.1038/nature08855.
95. Siu, C.O., Agid, O., Remington, G., Efficacy of antipsychotic drugs for schizophrenia. Lancet, 382, 2013, 1874, 10.1016/S0140-6736(13)62616-1.
96. Stark, K.L., Xu, B., Bagchi, A., Lai, W.-S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A. a, Karayiorgou, M., Gogos, J. a, Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40 (2008), 751–760, 10.1038/ng.138.
97. Stefansson, H., Meyer-Lindenberg, A., Steinberg, S., Magnusdottir, B., Morgen, K., Arnarsdottir, S., Bjornsdottir, G., Walters, G.B., Jonsdottir, G. a, Doyle, O.M., Tost, H., Grimm, O., Kristjansdottir, S., Snorrason, H., Davidsdottir, S.R., Gudmundsson, L.J., Jonsson, G.F., Stefansdottir, B., Helgadottir, I., Haraldsson, M., Jonsdottir, B., Thygesen, J.H., Schwarz, A.J., Didriksen, M., Stensbøl, T.B., Brammer, M., Kapur, S., Halldorsson, J.G., Hreidarsson, S., Saemundsen, E., Sigurdsson, E., Stefansson, K., CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505 (2014), 361–366, 10.1038/nature12818.
98. Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O.P.H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J.E., Hansen, T., Jakobsen, K.D., Muglia, P., Francks, C., Matthews, P.M., Gylfason, A., Halldorsson, B.V., Gudbjartsson, D., Thorgeirsson, T.E., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., Bjornsson, A., Mattiasdottir, S., Blondal, T., Haraldsson, M., Magnusdottir, B.B., Giegling, I., Möller, H.-J., Hartmann, A., Shianna, K.V., Ge, D., Need, A.C., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Paunio, T., Toulopoulou, T., Bramon, E., Di Forti, M., Murray, R., Ruggeri, M., Vassos, E., Tosato, S., Walshe, M., Li, T., Vasilescu, C., Mühleisen, T.W., Wang, A.G., Ullum, H., Djurovic, S., Melle, I., Olesen, J., Kiemeney, L.A., Franke, B., Sabatti, C., Freimer, N.B., Gulcher, J.R., Thorsteinsdottir, U., Kong, A., Andreassen, O.A., Ophoff, R.A., Georgi, A., Rietschel, M., Werge, T., Petursson, H., Goldstein, D.B., Nöthen, M.M., Peltonen, L., Collier, D.A., St, Clair, D., Stefansson, K., Kahn, R.S., Linszen, D.H., van Os, J., Wiersma, D., Bruggeman, R., Cahn, W., de Haan, L., Krabbendam, L., Myin-Germeys, I., Large recurrent microdeletions associated with schizophrenia. Nature 455 (2008), 232–236, 10.1038/nature07229.
99. Sullivan, P.F., Kendler, K.S., Neale, M.C., Schizophrenia as a Complex Trait. Arch. Gen. Psychiatry, 60, 2003, 1187, 10.1001/archpsyc.60.12.1187.
100. Swerdlow, N.R., Light, G.A., Sprock, J., Calkins, M.E., Green, M.F., Greenwood, T.A., Gur, R.E., Gur, R.C., Lazzeroni, L.C., Nuechterlein, K.H., Radant, A.D., Ray, A., Seidman, L.J., Siever, L.J., Silverman, J.M., Stone, W.S., Sugar, C.A., Tsuang, D.W., Tsuang, M.T., Turetsky, B.I., Braff, D.L., Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophr. Res. 152 (2014), 503–512, 10.1016/j.schres.2013.12.004.
101. Szatkiewicz, J.P., O'Dushlaine, C., Chen, G., Chambert, K., Moran, J.L., Neale, B.M., Fromer, M., Ruderfer, D., Akterin, S., Bergen, S.E., Kähler, a, Magnusson, P.K.E., Kim, Y., Crowley, J.J., Rees, E., Kirov, G., O'Donovan, M.C., Owen, M.J., Walters, J., Scolnick, E., Sklar, P., Purcell, S., Hultman, C.M., McCarroll, S. a, Sullivan, P.F., Copy number variation in schizophrenia in Sweden. Mol. Psychiatry 19 (2014), 762–773, 10.1038/mp.2014.40.
102. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872, 10.1016/j.cell.2007.11.019.
103. Tall, A.R., Yvan-Charvet, L., Wang, N., The failure of torcetrapib: was it the molecule or the mechanism?. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 257–260, 10.1161/01.ATV.0000256728.60226.77.
104. Tamada, K., Tomonaga, S., Hatanaka, F., Nakai, N., Takao, K., Miyakawa, T., Nakatani, J., Takumi, T., Decreased exploratory activity in a mouse model of 15q duplication syndrome: implications for disturbance of serotonin signaling. PLoS One, 5, 2010, e15126, 10.1371/journal.pone.0015126.
105. Walsh, T., McClellan, J.M., McCarthy, S.E., Addington, A.M., Pierce, S.B., Cooper, G.M., Nord, A.S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S.M., Rippey, C.F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R.L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E.E., Meltzer, P.S., Nelson, S.F., Singleton, A.B., Lee, M.K., Rapoport, J.L., King, M.-C., Sebat, J., Rare Structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 (2008), 539–543, 10.1126/science.1155174 (80-. ).
106. Walz, K., Caratini-Rivera, S., Bi, W., Fonseca, P., Mansouri, D.L., Lynch, J., Vogel, H., Noebels, J.L., Bradley, A., Lupski, J.R., Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol. Cell. Biol. 23 (2003), 3646–3655, 10.1128/MCB.23.10.3646-3655.2003.
107. Wang, Y., Medvid, R., Melton, C., Jaenisch, R., Blelloch, R., DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat. Genet. 39 (2007), 380–385, 10.1038/ng1969.
108. Warnica, W., Merico, D., Costain, G., Alfred, S.E., Wei, J., Marshall, C.R., Scherer, S.W., Bassett, A.S., Copy number variable micrornas in schizophrenia and their neurodevelopmental gene targets. Biol. Psychiatry 77 (2014), 158–166, 10.1016/j.biopsych.2014.05.011.
109. Weinberger, D.R., Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44 (1987), 660–669, 10.1001/archpsyc.1988.01800350089019.
110. Weiss, L.A., Shen, Y., Korn, J.M., Arking, D.E., Miller, D.T., Fossdal, R., Saemundsen, E., Stefansson, H., Ferreira, M.A.R., Green, T., Platt, O.S., Ruderfer, D.M., Walsh, C.A., Altshuler, D., Chakravarti, A., Tanzi, R.E., Stefansson, K., Santangelo, S.L., Gusella, J.F., Sklar, P., Wu, B., Daly, M.J., Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358 (2008), 667–675, 10.1056/NEJMoa075974.
111. Wen, L., Lu, Y.-S., Zhu, X.-H., Li, X.-M., Woo, R.-S., Chen, Y.-J., Yin, D.-M., Lai, C., Terry, A.V., Vazdarjanova, A., Xiong, W.-C., Mei, L., Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 1211–1216, 10.1073/pnas.0910302107.
112. Wen, Z., Nguyen, H.N., Guo, Z., Lalli, M. a, Wang, X., Su, Y., Kim, N.-S., Yoon, K.-J., Shin, J., Zhang, C., Makri, G., Nauen, D., Yu, H., Guzman, E., Chiang, C.-H., Yoritomo, N., Kaibuchi, K., Zou, J., Christian, K.M., Cheng, L., Ross, C. a, Margolis, R.L., Chen, G., Kosik, K.S., Song, H., Ming, G., Synaptic dysregulation in a human iPS cell model of mental disorders. Nat. Lett 515 (2014), 1–5, 10.1038/nature13716.
113. Yoon, K.-J., Nguyen, H.N., Ursini, G., Zhang, F., Kim, N.-S., Wen, Z., Makri, G., Nauen, D., Shin, J.H., Park, Y., Chung, R., Pekle, E., Zhang, C., Towe, M., Hussaini, S.M.Q., Lee, Y., Rujescu, D., St, Clair, D., Kleinman, J.E., Hyde, T.M., Krauss, G., Christian, K.M., Rapoport, J.L., Weinberger, D.R., Song, H., Ming, G., Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. Cell Stem Cell 15 (2014), 79–91, 10.1016/j.stem.2014.05.003.
114. Zhao, D., Lin, M., Chen, J., Pedrosa, E., Hrabovsky, A., Fourcade, H.M., Zheng, D., Lachman, H.M., MicroRNA profiling of neurons generated using induced pluripotent stem cells derived from patients with schizophrenia and schizoaffective disorder, and 22q11.2 Del. PLoS One, 10, 2015, e0132387, 10.1371/journal.pone.0132387.